Cas:1245563-13-6 3-(Benzyloxy)-5-chloro-2-ethoxypyridine manufacturer & supplier

Chemical Name:3-(Benzyloxy)-5-chloro-2-ethoxypyridine

CAS.NO:1245563-13-6

Synonyms:5-chloro-2-ethoxy-3-phenylmethoxypyridine

Molecular Formula:C₁₄H₁₄ClNO₂

Molecular Weight:263.71900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:31.35000

Exact Mass:263.07100

LogP:3.71270

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-chloro-2-ethoxy-3-phenylmethoxypyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-2-ethoxy-3-phenylmethoxypyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-2-ethoxy-3-phenylmethoxypyridine Use and application,5-chloro-2-ethoxy-3-phenylmethoxypyridine technical grade,usp/ep/jp grade.

Related News: The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. 3-(Benzyloxy)-5-chloro-2-ethoxypyridine manufacturer From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. 3-(Benzyloxy)-5-chloro-2-ethoxypyridine supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 3-(Benzyloxy)-5-chloro-2-ethoxypyridine vendor To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 3-(Benzyloxy)-5-chloro-2-ethoxypyridine factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.